peer reviewedAlready known as the first cause of mortality in men, non-small cell lung cancer (NSCLC) is nowadays a major cause of cancer-related death in women. Its approach relies on a thorough locoregional and extra-thoracic assessment allowing a precise staging which not only has prognostic value, but also determines the therapeutic options. This review presents the current multidisciplinary strategy agreement or the treatment of NSCLC.Résumé : Déjà reconnu comme la première cause de mortalité chez l’homme, le cancer broncho-pulmonaire non à petites cellules (CBNPC) est également devenu l’une des premières causes de décès par cancer chez la femme. Sa prise en charge repose sur un bilan locorégional, médiastinal et extra-thoracique ...
The present updated guidelines on the management of resectable non-small cell lung cancer (NSCLC) fo...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally adva...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
Non-small cell lung cancer (NSCLC) is a type of lung cancer and presently a prominent cause for deat...
The multidisciplinary management of lung cancer has been universally accepted. In France, the multid...
Lung cancer is a diagnosis that has risen to the top of the global cancer death toll. Adenocarcinoma...
The precocity of the diagnosis of non small lung cancers (NSCLC) is crucial. Only 30% of these tumou...
The present updated guidelines on the management of unresectable non-metastatic nonsmall cell lung c...
The management of non-small cell lung cancer (NSCLC) has evolved into a multidiscipli-nary team appr...
Lung cancer (LC) has become the leading cancer-related cause of death in the US and in developed Eur...
The majority of patients with non-small cell lung cancer (NSCLC) present with advanced stage at diag...
Purpose of review The majority of patients with non-small cell lung cancer (NSCLC) present with adva...
Oligometastatic non-small cell lung cancer (NSCLC) describes an intermediate stage of NSCLC between ...
The present updated guidelines on the management of resectable non-small cell lung cancer (NSCLC) fo...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally adva...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
Non-small cell lung cancer (NSCLC) accounts for approximately one in five cancer-related deaths, and...
Non-small cell lung cancer (NSCLC) is a type of lung cancer and presently a prominent cause for deat...
The multidisciplinary management of lung cancer has been universally accepted. In France, the multid...
Lung cancer is a diagnosis that has risen to the top of the global cancer death toll. Adenocarcinoma...
The precocity of the diagnosis of non small lung cancers (NSCLC) is crucial. Only 30% of these tumou...
The present updated guidelines on the management of unresectable non-metastatic nonsmall cell lung c...
The management of non-small cell lung cancer (NSCLC) has evolved into a multidiscipli-nary team appr...
Lung cancer (LC) has become the leading cancer-related cause of death in the US and in developed Eur...
The majority of patients with non-small cell lung cancer (NSCLC) present with advanced stage at diag...
Purpose of review The majority of patients with non-small cell lung cancer (NSCLC) present with adva...
Oligometastatic non-small cell lung cancer (NSCLC) describes an intermediate stage of NSCLC between ...
The present updated guidelines on the management of resectable non-small cell lung cancer (NSCLC) fo...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally adva...